General “News” category

The Lung Cancer Living Room: Q&A with Danielle Hicks, Chief Patient Officer

2020-01-09T15:34:07-06:00January 9th, 2020|Hot Topics, News|

Every month our Lung Cancer Living Room, a patient education and support series, brings hope home to patients and their families around the world. Through presentations by experts in the field, this unrestricted forum covers all topics, from early detection to personalized medicine and beyond. As the first lung cancer support group of its kind, the Lung Cancer Living Room brings you the feeling of home, whether you are part of the live audience or watch from your own living [...]

Advances in Lung Cancer Treatment Drops U.S. Cancer Deaths

2020-01-09T08:41:58-06:00January 9th, 2020|Hot Topics, News|

GO2 Foundation for Lung Cancer points to targeted treatments and early screenings SAN CARLOS, Calif. and WASHINGTON, Jan. 8, 2020 /PRNewswire/ -- Today's report concerning improvements in cancer mortality is welcomed news. The recently released Cancer Statistics 2020 report shows that the decline in lung cancer deaths is driving the decrease in mortality rates for cancer overall. This is a tremendous development for anyone who is at-risk or managing a cancer diagnosis. "This report validates what we have been advocating for many years. Lung cancer is a [...]

Year-end Progress for the Lung Cancer Community: Federal Research Funding & the Women and Lung Cancer Research and Preventive Services Act

2019-12-21T09:28:40-06:00December 21st, 2019|Hot Topics, News|

For many weeks, our community has been awaiting passage of the Fiscal Year 2020 (FY20) federal budget, which funds the Lung Cancer Research Program. This week, just days before the budget continuing resolution expired, the House and Senate released the long-awaited conferenced agreement that has been signed by the President to avert a repeat of last year's holiday-time government shutdown. In anticipation of this effort, GO2 Foundation for Lung Cancer (a recent merger of Lung Cancer Alliance and the Bonnie [...]

Lung Cancer Registry Launches New Surveys

2019-12-13T08:41:07-06:00December 13th, 2019|Hot Topics, News|

SAN CARLOS, Calif. and WASHINGTON DC, December 12, 2019 – The Lung Cancer Registry has launched new surveys to do an even better job of capturing important moments in a patient’s lung cancer journey. These new surveys include questions about how symptoms and side effect impact quality of life—now and over time. With many innovative treatments available for lung cancer, the new survey modules will now track not only the drugs and treatments that patients received but also the sequence in [...]

FDA Approves Tecentriq Plus Chemotherapy as a First-Line Treatment for Metastatic NSCLC

2019-12-05T15:38:08-06:00December 5th, 2019|Hot Topics, News|

On December 3, 2019, the U.S. Food and Drug Administration approved Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane [paclitaxel protein-bound; nab-paclitaxel] and carboplatin) as a first treatment for patients with metastatic non-squamous non-small cell lung cancer (NSCLC) with no EGFR or ALK changes. This approval is based on the Phase III IMpower130 study which showed that Tecentriq in combination with chemotherapy helped people live significantly longer than chemotherapy alone. This approval offers a new combination therapy option to improve survival [...]

GO2 Foundation for Lung Cancer Announces Young Innovators Team Award Recipients

2019-12-03T13:36:35-06:00December 3rd, 2019|Hot Topics, News|

SAN CARLOS, Calif., Dec. 3, 2019 -- GO2 Foundation for Lung Cancer announced the recipients of the 2019 Young Innovators Team Awards (YITA) today. Two teams of researchers received grants totaling $500,000 for their work developing novel strategies to treat KRAS-mutant non-small cell lung cancer (NSCLC) and examining the impact of age on development, progression, and immunotherapy response in NSCLC. "The lack of institutional research funding for lung cancer creates a disincentive for talented young scientists and doctors to pursue research in this area, but we are [...]

Welcome to Belong, a New Online Cancer Community

2019-08-22T13:59:06-06:00August 21st, 2019|Hot Topics, News|

GO2 Foundation has partnered with Belong.Life to provide patient and caregiver support and education on the world’s largest social network for cancer patients. Within the GO2 Foundation membership area, our social workers, clinical trial specialists, and survivor-volunteers will provide hope, education, and support for those living with lung cancer. Members will get the latest treatment updates, access to GO2 Foundation’s suite of educational materials, an appointment tracker, an area to store medical documents, and peer-to-peer support. "The Belong app, to me, [...]

FDA Approves Genentech’s Rozlytrek (entrectinib) for ROS1 Non-Small Cell Lung Cancer (NSCLC) and NTRK-Driven Tumors

2019-08-16T10:54:48-06:00August 16th, 2019|Hot Topics, News|

On August 15, 2019 the U.S. Food and Drug Administration approved Rozlytrek (entrectinib) for the treatment of patients with ROS1-positive, metastatic non-small cell lung cancer. It was also simultaneously approved for the treatment of patients with any solid tumor that is NTRK fusion-positive, following progression on other therapies. This approval offers a new targeted therapy option for patients with both of these rare mutations and is only the third time that the FDA has approved a targeted therapy for any [...]

GO2 Foundation Presents 2019 Bonnie J. Addario Lectureship Award at ILCC

2019-08-15T10:46:56-06:00August 2nd, 2019|Hot Topics, News|

GO2 Foundation for Lung Cancer is pleased to announce that it presented Solange Peters, MD, PhD, with the 2019 Bonnie J. Addario Lectureship Award for her emphasis on groundbreaking biomarker research, improving access to care for lung cancer patients worldwide, and supporting the advancement of women in oncology. GO2 Foundation honored Prof. Peters with the award at the International Lung Cancer Conference (ILCC) held July 25-27 in Huntington Beach, California. Read more.

An Update on the Burn Pits Accountability Act of 2019

2019-07-17T10:10:20-06:00July 17th, 2019|Hot Topics, News|

Click here to read our statement in support of the legislation. GO2 Foundation for Lung Cancer is pleased to report the recent advancement of the Burn Pits Accountability Act. We strongly support this legislation as a first step to ensure that all those affected by burn pit toxins are accounted for, in order to call for further research focused on these veterans. Since the Persian Gulf War, a common waste disposal practice at military sites outside the United States was [...]